Business59 mOctober 16, 2026, 10:20

Nvidia-backed AI drug developer Iambic raises $150m in IPO

Iambic, an AI drug developer backed by Nvidia, raised $150 million in its IPO. The company will use the proceeds to advance three early-stage cancer drug candidates.

Tech in Asia

Open source

Nvidia-backed AI drug developer Iambic raises $150m in IPO

Iambic raised $150 million in its IPO
The company is backed by Nvidia
Proceeds will fund three early-stage cancer drug candidates

#Nvidia#Iambic

Arcee AI, which develops open-weight models in the US, raised a Series B at a $1B pre-money valuation; a source says Arcee raised at least $150M (Allie Garfinkle/Fortune)

Business

AI Data Center Developer LIAN Eyes IPO to Raise $500 Million

Business

Nvidia-backed Firmus to postpone IPO, weighs private round

Business

Nvidia-backed AI drug developer Iambic raises $150m in IPO

Arcee AI, which develops open-weight models in the US, raised a Series B at a $1B pre-money valuation; a source says Arcee raised at least $150M (Allie Garfinkle/Fortune)

AI Data Center Developer LIAN Eyes IPO to Raise $500 Million

Nvidia-backed Firmus to postpone IPO, weighs private round

Nvidia-Backed Data Center IPO Sees Cratering Demand